Cardiff Oncology Inc. (CRDF)
Get Email Alerts Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | VenBio Select Advisor Kurt Von Emster | 1,000,000 | $5,010 | 0.09% | |
| 2. | Opaleye Management James A. Silverman | 590,000 | $2,956 | 0.59% | |
| 3. | Acuta Capital Partners Manfred Yu | 407,500 | $2,042 | 0.58% | |
| 4. | Renaissance Technologies Jim Simons | 268,800 | $1,347 | 0% | |
| 5. | Corriente Advisors Mark Hart Iii | 173,361 | $869 | 0.56% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $5.71 | 850 | Director | 450,311 | 2020-09-16 | Filing | |
| $5.69 | 1,700 | Director | 449,461 | 2020-09-16 | Filing | |
| $1.43 | 6,993 | Officer | 13,369 | 2020-05-14 | Filing | |
| $1.43 | 20,979 | Director | 28,160 | 2020-05-14 | Filing | |
| $1.43 | 6,993 | Director | 9,260 | 2020-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.69 | 8,334 | Director | 209,394 | 2017-09-05 | Filing | |
| $8.64 | 4,200 | Director | 326,486 | 2013-09-03 | Filing | |
| $8.06 | 15,000 | Director | 330,686 | 2013-08-30 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,595,164 | $7,992 | 8.43% | |
| 2. | 294,376 | $1,475 | 0% | |
| 3. | 135,650 | $680 | 0.01% | |
| 4. | 96,400 | $483 | 0.04% | |
| 5. | 36,950 | $185 | 0.09% |
Billionaire Hedge Funds
